Zhang, Q., Qin, N., Wang, J., Lv, J., Yang, X., Li, X., . . . Zhang, S. (2015). Crizotinib versus platinum‐based double‐agent chemotherapy as the first line treatment in advanced anaplastic lymphoma kinase‐positive lung adenocarcinoma. Thorac Cancer.
শিকাগো স্টাইলে সাইটেশনZhang, Quan, et al. "Crizotinib Versus Platinum‐based Double‐agent Chemotherapy As the First Line Treatment in Advanced Anaplastic Lymphoma Kinase‐positive Lung Adenocarcinoma." Thorac Cancer 2015.
এমএলএ সাইটেশনZhang, Quan, et al. "Crizotinib Versus Platinum‐based Double‐agent Chemotherapy As the First Line Treatment in Advanced Anaplastic Lymphoma Kinase‐positive Lung Adenocarcinoma." Thorac Cancer 2015.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.